Focus Partners Advisor Solutions LLC decreased its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 63.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,721 shares of the real estate investment trust's stock after selling 8,357 shares during the quarter. Focus Partners Advisor Solutions LLC's holdings in National Health Investors were worth $327,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Barclays PLC increased its stake in National Health Investors by 323.8% in the 3rd quarter. Barclays PLC now owns 71,703 shares of the real estate investment trust's stock worth $6,027,000 after acquiring an additional 54,782 shares during the last quarter. Inspire Investing LLC grew its holdings in shares of National Health Investors by 17.2% in the fourth quarter. Inspire Investing LLC now owns 5,775 shares of the real estate investment trust's stock valued at $400,000 after purchasing an additional 847 shares in the last quarter. Nepsis Inc. increased its position in National Health Investors by 58.9% in the fourth quarter. Nepsis Inc. now owns 107,721 shares of the real estate investment trust's stock worth $7,465,000 after purchasing an additional 39,913 shares during the last quarter. Blue Trust Inc. raised its stake in National Health Investors by 30.3% during the fourth quarter. Blue Trust Inc. now owns 4,635 shares of the real estate investment trust's stock valued at $321,000 after purchasing an additional 1,078 shares in the last quarter. Finally, KBC Group NV raised its stake in National Health Investors by 61.4% during the fourth quarter. KBC Group NV now owns 2,019 shares of the real estate investment trust's stock valued at $140,000 after purchasing an additional 768 shares in the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.
National Health Investors Trading Down 0.4%
Shares of NHI traded down $0.28 during mid-day trading on Friday, reaching $72.65. 141,661 shares of the company's stock traded hands, compared to its average volume of 229,878. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The stock's 50-day moving average is $74.00 and its two-hundred day moving average is $72.43. National Health Investors, Inc. has a 12 month low of $64.00 and a 12 month high of $86.13. The stock has a market cap of $3.39 billion, a P/E ratio of 24.93, a P/E/G ratio of 4.42 and a beta of 0.78.
National Health Investors (NYSE:NHI - Get Free Report) last released its earnings results on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.13 by $0.02. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $68.87 million for the quarter, compared to analyst estimates of $85.13 million. During the same quarter last year, the firm posted $1.10 earnings per share. The business's revenue was up 9.6% compared to the same quarter last year. Research analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.
National Health Investors Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be issued a $0.90 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.60 annualized dividend and a yield of 4.95%. National Health Investors's dividend payout ratio (DPR) is presently 114.29%.
Analysts Set New Price Targets
A number of research firms have recently weighed in on NHI. Wedbush restated an "outperform" rating and issued a $88.00 target price on shares of National Health Investors in a report on Monday, March 17th. Truist Financial boosted their target price on National Health Investors from $70.00 to $76.00 and gave the company a "hold" rating in a research report on Wednesday, March 19th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $85.50.
Get Our Latest Stock Analysis on NHI
National Health Investors Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.